Exclusive

Publication

Byline

Location

US Patent Issued to INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY on June 30 for "Retinoic acid precursor and anticancer drug composition comprising same" (South Korean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,580, issued on June 30, was assigned to INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY (Jeonju-si, South Korea). "Retinoic a... Read More


US Patent Issued to THE TEXAS A&M UNIVERSITY SYSTEM on June 30 for "Therapeutics for treatment of COVID-19 symptoms" (Texas, California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,581, issued on June 30, was assigned to THE TEXAS A&M UNIVERSITY SYSTEM (College Station, Texas). "Therapeutics for treatment of COVID-19 s... Read More


US Patent Issued to ADVANCED PROTEIN TECHNOLOGIES on June 30 for "Composition containing 2'-FL for ameliorating, preventing or treating diseases caused by reduction of dopamine" (South Korean, Taiwanese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,582, issued on June 30, was assigned to ADVANCED PROTEIN TECHNOLOGIES CORP. (Suwon-si, South Korea). "Composition containing 2'-FL for amel... Read More


US Patent Issued to HENAN GENUINE BIOTECH on June 30 for "Method for preventing or treating a cornavirus infectious disease" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,583, issued on June 30, was assigned to HENAN GENUINE BIOTECH Co. LTD. (Pingdingshan, China). "Method for preventing or treating a cornavir... Read More


US Patent Issued to NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING on June 30 for "Adenosine analog and its use in regulating the circadian clock" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,584, issued on June 30, was assigned to NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (Beijing). "Adenosine analog and its use in regu... Read More


US Patent Issued to Wake Forest University Health Sciences on June 30 for "Immunotherapeutic nanoparticles and methods relating thereto" (North Carolina Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,585, issued on June 30, was assigned to Wake Forest University Health Sciences (Winston-Salem, N.C.). "Immunotherapeutic nanoparticles and ... Read More


US Patent Issued to Glaukos on June 30 for "Treatments for ocular surface disorders" (American, New Zealander Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,586, issued on June 30, was assigned to Glaukos Corp. (Aliso Viejo, Calif.). "Treatments for ocular surface disorders" was invented by Shaw... Read More


US Patent Issued to Mandos on June 30 for "Hydroxypropyl beta-cyclodextrin compositions and methods" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,587, issued on June 30, was assigned to Mandos LLC (Thousand Oaks, Calif.). "Hydroxypropyl beta-cyclodextrin compositions and methods" was ... Read More


US Patent Issued to Mandos on June 30 for "Hydroxypropyl beta-cyclodextrin compositions and methods" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,588, issued on June 30, was assigned to Mandos LLC (Thousand Oaks, Calif.). "Hydroxypropyl beta-cyclodextrin compositions and methods" was ... Read More


US Patent Issued to Mandos on June 30 for "Hydroxypropyl beta-cyclodextrin compositions and methods" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,589, issued on June 30, was assigned to Mandos LLC (Thousand Oaks, Calif.). "Hydroxypropyl beta-cyclodextrin compositions and methods" was ... Read More